Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving treatment adherence for metabolic health in Negev Bedouins

Official title: Examining the Effectiveness of Family and Community-Based Intervention Programs to Improve Treatment Adherence for Overweight, Obesity, Prediabetes, Metabolic Syndrome, and Type 2 Diabetes in the Bedouin Community in the Negev

Run by Ariel University · NCT06575465 · Data updated 2026-11-12

This study is testing a family-focused program to help Bedouins in the Negev stick to a healthier lifestyle to better manage type 2 diabetes and obesity.

More Community Based Participatory Research trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment170 (estimated)
SponsorAriel University
Academic / other
Locations1 site (Rahat)
StatusRecruiting
StartedSeptember 1, 2024
Main results expectedDecember 31, 2025
Study endsMay 31, 2026
Registry record updatedJanuary 28, 2025
Trial IDNCT06575465 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include Bedouin men and women aged 18 and above who are diagnosed with overweight, obesity, metabolic syndrome, prediabetes, or type 2 diabetes.

Probably not a fit

Patients with other chronic diseases that may interfere with the study or those who are pregnant or lactating may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a family-centered intervention program aimed at improving treatment adherence for metabolic health among the Bedouin community in the Negev, which faces high rates of type 2 diabetes and obesity. The intervention consists of 10 sessions over 12 months focusing on nutrition, physical activity, and cultural aspects to promote adherence to a Mediterranean diet. Participants will be assessed for changes in fasting glucose, HbA1c, lipid profiles, BMI, physical activity, and quality of life. The study employs a controlled community intervention design with two groups: one receiving the intervention and the other serving as a control.

Why it matters

Potential benefit: If successful, this intervention could significantly improve metabolic health outcomes and treatment adherence in the Bedouin community.

How similar studies have gone: Other studies have shown success with community-based participatory approaches in improving health outcomes, suggesting potential for this culturally tailored intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Bedouin men and women aged 18 and above
* Diagnosed with overweight, obesity, metabolic syndrome, prediabetes, or type 2 diabetes
* Consent to participate in the study

Exclusion Criteria:

* Individuals with other chronic diseases that might interfere with the study
* Pregnant or lactating women
* Individuals unable to provide informed consent

Where it's running

  • Clalit healthcare clinic
    Rahat, Israel
    Recruiting

Study contacts

  • Principal investigator: Muflah Ataika, MD — Rahat Counseling Clinic, Southern District, Clalit Health Services.
  • Study coordinator: Vered Kaufman-Shriqui, PhD
  • Email: veredks@ariel.ac.il
  • Phone: +972587751199

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Cocreating local actions to make healthcare more rational

    This project will test whether working with residents in Elche to cocreate community actions can reduce unnecessary use of mental‑health drugs, cardiovascular medications, and antibiotics and ease pressure on primary care.

    Recruiting at 2 sites Universidad Miguel Hernandez de Elche · Elche, Alicante and 1 other locations · NCT07237971

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.